Validated target genes include CLEC16A and SOCS1. While these genes have been previously implicated in type 1 diabetes and other autoimmune diseases, we show that enhancers controlling their expression harbor functional variants. The gene discussed is CLEC16A; the disease is type 1 diabetes mellitus.